© 2026 Sinochem Nanjing Corporation,
All Right Reserved
Nifuratel stands out as a synthetic nitrofuran derivative, usually identified by its pale-yellow or light-brown, crystalline powder form. This compound carries the molecular formula C10H11N3O5S and a molar mass of 285.28 g/mol. People concerned with chemical substances often check its CAS number, 4936-47-4, for accurate reference. The HS Code, typically 2934999099, helps track its international trade. Nifuratel presents itself as a reliable pharmaceutical raw material known for broad antimicrobial and antiparasitic activities. It takes noticeable importance for those in medical and pharmaceutical fields because of its proven impact on various infections, especially in gynecology and urology.
Handling Nifuratel, one quickly notices its mild, almost unremarkable odor and a bitter taste. Its density falls around 1.46 g/cm³. Rarely soluble in water under room temperature, it does better in ethanol, chloroform, and DMSO, revealing its preference for organic solvents when used in laboratory or industrial contexts. Often found in a flaky, powdery or crystalline solid state, Nifuratel is stable at room temperature but should be stored in a cool, dry place to prevent moisture absorption and light degradation. For those dealing with laboratory preparation or quality control, checking particle size and homogeneity becomes vital—factors that influence accuracy in formulation and processing. The color and texture give some clues about batch purity, with uniform crystals indicating high quality, while off-colors suggest contamination.
The structure of Nifuratel involves the fusion of a nitrofuran ring with a thiazole ring, along with a methylthio group, giving it unique antibacterial and antiprotozoal qualities. This structure supports its action by interfering with enzymes essential for the survival of many bacterial and protozoal organisms. Those engaged in molecular modeling or material sciences recognize the significance of the orientation of these functional groups, as their placement impacts both efficacy and synthetic accessibility. The consistency of crystals and powder properties hints at the effectiveness of manufacturing and material handling processes. Purity standards and batch testing remain crucial at every stage to verify the absence of hazardous by-products or impurities.
Nifuratel usually comes with a set of specifications, including aspects such as appearance, assay, melting point (usually around 175–177°C), specific rotation, solubility profile, impurity thresholds, and loss on drying. For those involved in bulk raw material procurement, these characteristics draw the line between a reliable product and a risky shipment. Considering its classification, safe storage and handling routines follow strict chemical standards—Nifuratel can irritate the skin, eyes, and respiratory tract. Gloves, masks, and proper ventilation should never be regarded as optional for employees or anyone handling large amounts. Regulatory documentation typically recommends storing it away from heat, moisture, and incompatible substances such as strong oxidizers. In the event of accidental exposure, quick removal from contaminated areas and thorough washing help minimize harm, and medical advice ensures safety. Waste disposal procedures become relevant; Nifuratel waste belongs in special chemical waste containers, not down the sink or regular trash.
The molecular nature of Nifuratel shapes not just its effectiveness but also the way industries scale up solutions and intermediate preparations. Its relatively low solubility in water can create bottlenecks or opportunities for innovative formula development, such as micronization or new solvent mixtures. Companies and laboratories looking to improve bioavailability or dosage forms will often support research in these areas, leading to patents and proprietary blends that raise the bar for patient outcomes. Analytical chemists regularly examine the material for polymorphic forms, which could alter solubility or stability and influence shelf life. These controls perform a crucial role in both product safety and therapeutic consistency. The undertaking of finding safer, less hazardous alternatives for any potentially harmful additives or synthesis reagents continues, since consumer and employee safety standards keep getting stricter day by day.
Direct, unprotected exposure to raw Nifuratel presents some risks—known hazards include respiratory irritation, skin sensitization, and allergic reactions, particularly for workers in manufacturing or formulation lines. Extended exposure through inhalation or skin contact increases the risk of sensitization turning into more serious health issues. Anyone with a stake in chemical manufacturing or workplace safety should keep in mind the importance of comprehensive safety data sheets and up-to-date training. For every risk shown by animal studies or toxicology reports, diligent record keeping and traceability reinforce accountability within supply chains and labs. No one can afford to ignore regular environmental monitoring and workplace air sampling, both of which help prevent long-term health impacts in plants where Nifuratel’s presence is constant and persistent.
Pharmaceutical companies and contract manufacturers put Nifuratel to use almost exclusively in the production of antimicrobial medicines, targeting problems harmful to women’s and urinary health. The known risk of allergic reactions and the challenge of solubility push people in research and development to continually look for better formulations, delivery methods, and safer analogs. One practical solution emerges from investment in advanced filtration, micro-encapsulation, and risk-minimizing production practices. Forward-thinking companies invite third-party audits, use safer manufacturing systems, and promote transparency for buyers and regulatory bodies, raising trust and public health standards. Educational campaigns could help downstream users, like pharmacists and hospital staff, understand how to handle and store Nifuratel-based products, reducing accidental misuse or exposure.
Reliable suppliers recognize that providing Nifuratel goes beyond a simple sale—it involves rigorous batch certification, accurate labeling, constant monitoring for contaminants, and transparent communication. Pharmaceutical quality depends totally on the raw materials, as substandard bulk Nifuratel can taint formulations or, worse, put patients at risk through unsafe levels of impurities. For this reason, more industries turn to advanced analytical methods—high-performance liquid chromatography, mass spectrometry, and even genetic impact studies—to certify the substance’s safety and quality. Regulatory collaboration supports safer outcomes, with stronger reporting and product recall mechanisms catching problems faster. Global markets reflect these priorities by favoring suppliers who stand behind their product, invest in better compliance systems, and demonstrate a real understanding of the substance’s strengths and gaps. Every company and worker handling Nifuratel shapes the future of chemical safety, therapeutic development, and public health.
